Division
HEAL Study
Investigator(s)
Title
Assessment Of Potential Interactions Between Intravenous Methamphetamine And Oral Selegiline
Short Description
This is a human laboratory clinical pharmacology study to assess potential interactions between intravenous methamphetamine challenge and treatment with oral selegiline.
Release Date
Aug 01, 2016
Description

The primary objective of this study is to determine the safety of the selegiline concurrent with dmethamphetamine challenges of 15 mg and 30 mg i.v. The primary outcome measures are cardiovascular responses (HR, BP) to the i.v. methamphetamine challenges.

Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Data
Study Links
Study Documents
Case Report Form(s)
Deidentification Notes
Nulled Values
All Documents
Division
HEAL Study
Investigator(s)
Title
Assessment Of Potential Interactions Between Intravenous Cocaine And Tolcapone
Short Description
This is a human laboratory clinical pharmacology study to assess potential interactions between intravenous cocaine infusion and treatment with tolcapone.
Release Date
Aug 01, 2016
Description

The primary objective of this study is to determine the safety of tolcapone treatment, compared to placebo treatment, concurrent with i.v. cocaine infusions of 20 and 40 mg, with the focus being on cardiovascular responses (HR, BP) to the i.v. cocaine infusions.

Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Data
Study Links
Study Documents
Case Report Form(s)
Deidentification Notes
Nulled Values
All Documents
Division
HEAL Study
Title
Safety Evaluation Of Cocaine Treatment Medication, Modafinil: Interactions With Intravenous Cocaine
Short Description
A study to evaluate modafinil, a cocaine treatment medication, and its interactions with intravenous (IV) cocaine.
Release Date
Aug 01, 2016
Description

The primary objectives of this study are to determine:
1. The safety/tolerability of modafinil as a cocaine treatment medication in cocaine dependent subjects.
2. If administration of intravenous cocaine to subjects (who have demonstrated ability to tolerate the intravenous (i.v.) cocaine administration) maintained on modafinil results in any adverse effects.
3. To determine if there is a pharmacokinetic interaction between cocaine and modafinil.
The secondary objective is to determine: The ability of modafinil to modify the cocaine-related “high” as well as dysphoric reactions to cocaine withdrawal.

Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Data
Study Links
Study Documents
Case Report Form(s)
Deidentification Notes
Nulled Values
All Documents

Profile of Mood States

Submitted by administrator on
Abbreviation
POMS
Description

Since its release in 1971, the POMS assessment has proven itself to be an excellent measure of affective mood state fluctuation in a wide variety of populations including psychiatric outpatients, medical patients, and in sports psychology. It is suitable for individuals aged 18 and older, and can be completed individually or in groups. The POMS Standard uses a 65-item, 5-point adjective rating scale, while the POMS Brief is based on 30 questions. Both versions of POMS measure six identifiable mood or affective states: Tension-Anxiety, Depression-Dejection, Anger-Hostility, Vigor-Activity, Fatigue-Inertia, and Confusion-Bewilderment.

Category
Mental Health
Subcategory
General/Multiple Disorders

Brief Psychiatric Rating Scale

Submitted by administrator on
Abbreviation
BPRS
Description

The BPRS is a clinician-rated tool designed to assess change in severity of psychopathology. It has been in widespread use for more than 30 years and remains popular for research studies that assess patient change in response to treatment interventions. It is an 18-item scale measuring positive symptoms, general psychopathology and affective symptoms. Each symptom construct is rated on a 7-point scale of severity ranging from 'not present' to 'extremely severe.' It takes approximately 20-30 minutes to administer the BPRS.

Category
Mental Health
Subcategory
General/Multiple Disorders

Structured Clinical Interview for DSM Disorders

Submitted by administrator on
Abbreviation
SCID
Description

The SCID-I is a semi-structured interview used to assess the major DSM-IV Axis I diagnoses. The SCID-II is a semi-structured interview for making Axis II (Personality Disorder) diagnoses. Each instrument comes in two versions -- the clinician version, a streamlined version published in two parts, and the research version, which is much easier to modify for a particular study and is more complete. The instrument is designed to be administered by a clinician or trained mental health professional and takes between 1 to 2 hours to complete. Because of its modular format, the SCID can be shortened by focusing only on the diagnoses of interest.

Category
Mental Health
Subcategory
General/Multiple Disorders